Skip to main content
SpringerLink
Log in

The properties of neuraminidase-treated crystalline ceruloplasmin

  • Specialia
  • Chimica, Biochimica, Biophysica
  • Published:
Experientia Aims and scope Submit manuscript

Résumé

On sait que la plasmine céruléenne crystalline rétroplacentaire humaine ainsi qua la plasmine apocérulécnne empêchent l'hémaglutination virale. Cet effet pourrait être attribué aux résidus d'acide sialique, car l'action préventive disparaît après traitement de la plasmine céruléenne par la neuraminidase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Institute for Medical Biochemistry, University of Oslo, Oslo, Norway

    C. A. Johnson, R. A. Løvstad, E. Walaas & O. Walaas

Authors
  1. C. A. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. A. Løvstad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Walaas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Walaas
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, C.A., Løvstad, R.A., Walaas, E. et al. The properties of neuraminidase-treated crystalline ceruloplasmin. Experientia 26, 134–135 (1970). https://doi.org/10.1007/BF01895536

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01895536

Search

Navigation